Paradigm Biocapital Advisors Lp - Net Worth and Insider Trading
Paradigm Biocapital Advisors Lp Net Worth
The estimated net worth of Paradigm Biocapital Advisors Lp is at least $35 Million dollars as of 2024-12-27. Paradigm Biocapital Advisors Lp is the 10% Owner of Olema Pharmaceuticals inc and owns about 5,503,600 shares of Olema Pharmaceuticals inc (OLMA) stock worth over $35 Million. Details can be seen in Paradigm Biocapital Advisors Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paradigm Biocapital Advisors Lp has not made any transactions after 2024-08-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paradigm Biocapital Advisors Lp
Paradigm Biocapital Advisors Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paradigm Biocapital Advisors Lp owns 1 companies in total, including Olema Pharmaceuticals inc (OLMA) .
Click here to see the complete history of Paradigm Biocapital Advisors Lp’s form 4 insider trades.
Insider Ownership Summary of Paradigm Biocapital Advisors Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals inc | 2024-08-01 | 10 percent owner |
Paradigm Biocapital Advisors Lp Latest Holdings Summary
Paradigm Biocapital Advisors Lp currently owns a total of 1 stock. Paradigm Biocapital Advisors Lp owns 5,503,600 shares of Olema Pharmaceuticals inc (OLMA) as of August 1, 2024, with a value of $35 Million.
Latest Holdings of Paradigm Biocapital Advisors Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals inc | 2024-08-01 | 5,503,600 | 6.32 | 34,782,752 |
Holding Weightings of Paradigm Biocapital Advisors Lp
Paradigm Biocapital Advisors Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Paradigm Biocapital Advisors Lp has made a total of 2 transactions in Olema Pharmaceuticals inc (OLMA) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Olema Pharmaceuticals inc is the sale of 2,400,000 shares on August 1, 2024, which brought Paradigm Biocapital Advisors Lp around $36 Million.
Insider Trading History of Paradigm Biocapital Advisors Lp
- 1
Paradigm Biocapital Advisors Lp Trading Performance
GuruFocus tracks the stock performance after each of Paradigm Biocapital Advisors Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paradigm Biocapital Advisors Lp is 22.1%. GuruFocus also compares Paradigm Biocapital Advisors Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paradigm Biocapital Advisors Lp within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paradigm Biocapital Advisors Lp's insider trading performs compared to the benchmark.
Performance of Paradigm Biocapital Advisors Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.71 | | | | | |
| Relative Return to S&P 500(%) | -6.96 | | | | | |
Paradigm Biocapital Advisors Lp Ownership Network
Paradigm Biocapital Advisors Lp Owned Company Details
What does Olema Pharmaceuticals inc do?
Who are the key executives at Olema Pharmaceuticals inc?
Paradigm Biocapital Advisors Lp is the 10 percent owner of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include director & Chief Technology Officer Cyrus Harmon , director & President and CEO Sean Bohen , and Chief Development Officer David C. Myles .
Olema Pharmaceuticals inc (OLMA) Insider Trades Summary
Over the past 18 months, Paradigm Biocapital Advisors Lp made 2 insider transaction in Olema Pharmaceuticals inc (OLMA) with a net sale of 2,300,000. Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 334,574 shares made by Cyrus Harmon , a net sale of 2,410,761 shares made by G. Walmsley Graham , and a net sale of 70,436 shares made by David C. Myles .
In summary, during the past 3 months, insiders sold 1,616,447 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 700,761 shares, with a net sale of 915,686 shares. During the past 18 months, 6,819,521 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,946,693 shares were bought by its insiders, resulting in a net sale of 3,872,828 shares.
Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Olema Pharmaceuticals inc Insider Transactions
Paradigm Biocapital Advisors Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Paradigm Biocapital Advisors Lp. You might contact Paradigm Biocapital Advisors Lp via mailing address: 767 Third Avenue, 17th Floor, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
